Synonyms Refractory High Risk Myelodysplastic Syndrome |
Introduction High risk myelodysplastic syndrome that does not respond to treatment. |
Target |
Mechanism Telomerase inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date06 Jun 2024 |
Mechanism DNA-directed DNA polymerase inhibitors [+2] |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date03 Aug 2017 |
Target |
Mechanism CD123 inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date30 Aug 2024 |
Sponsor / Collaborator |
Start Date26 Apr 2024 |
Sponsor / Collaborator Remix Therapeutics, Inc.Startup |
Start Date14 Apr 2024 |
Sponsor / Collaborator |